National Institutes of Health: all 11,571 studies

Page 99 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Honolulu Heart ProgramCompletedNCT00005123
• Evans County StudiesCompletedNCT00005122
• Framingham Heart StudyCompletedNCT00005121
• Altered Calcium and Vitamin D in PMDD or Severe PMSCompletedNCT00005119Not applicable
• Effect of Pravastatin on Endothelial Dysfunction Following a Single High Fat MealStatus unknownNCT00005117Not applicable
• Depression In Juvenile DiabeticsCompletedNCT00005116Not applicable
• Growth Hormone Use in Cystic Fibrosis - a Multicenter StudyCompletedNCT00005112Phase 3
• PET Scans in Normal Volunteers and Patients With Fabry DiseaseCompletedNCT00005111
• A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic FibrosisSuspendedNCT00005110Not applicable
• Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery WallsCompletedNCT00005108Phase 2
• Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and EndotoxemiaStatus unknownNCT00005107Phase 1
• Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth RetardationStatus unknownNCT00005105
• Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary SyndromeCompletedNCT00005104Not applicable
• Study of the Pathogenesis of Porphyria Cutanea TardaCompletedNCT00005103
• Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial SyndromeStatus unknownNCT00005102
• Study of Low Bone Mass in Premenopausal or Perimenopausal WomenCompletedNCT00005101
• Measurement of Outcome of Surgical Treatment in Patients With AcromegalyStatus unknownNCT00005100
• Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin DeficiencyTerminatedNCT00005098
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove PolypsCompletedNCT00005094Phase 3
• Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerCompletedNCT00005085Phase 2
• 506U78 in Treating Patients With LymphomaCompletedNCT00005080Phase 2
• Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate CancerTerminatedNCT00005067Phase 1
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerCompletedNCT00005065Phase 1
• PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeCompletedNCT00005064Phase 1
• Gene Therapy and Ganciclovir in Treating Patients With Stage IV MelanomaCompletedNCT00005057Phase 1
• Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)TerminatedNCT00005039Phase 2
• Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00005036Phase 3
• Observing Patients With Early HIV InfectionCompletedNCT00005020
• Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of HolopresencephalyCompletedNCT00005016
• Treatment of Depression in Youth With Bipolar DisordersTerminatedNCT00005015Phase 3
• Treatment of Autism in Children and AdolescentsCompletedNCT00005014Phase 3
• Treatment of Major Depression With St. John's Wort (Hypericum)CompletedNCT00005013Not applicable
• Combined Hormone Replacement in Menstrually-Related Mood DisordersCompletedNCT00005011
• Prevention of Kidney Transplant RejectionCompletedNCT00005010Phase 3
• Evaluation of the Safety of Varivax® in Pediatric Renal Transplant RecipientsTerminatedNCT00005009Phase 1
• Etanercept for Wegener's GranulomatosisCompletedNCT00005007Phase 2/3
• Brain Processing of Language MeaningsCompletedNCT00005004
• Genetic Component of HandednessCompletedNCT00005003
• Leucovorin for the Treatment of 5 q Minus SyndromeCompletedNCT00004997Phase 2
• Comparison of Immune Response in Normal Volunteers and Patients With Helminth InfectionsCompletedNCT00004996
• Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow TransplantCompletedNCT00004994
• Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced OsteoporosisCompletedNCT00004993Phase 2
• Diabetes Prevention ProgramCompletedNCT00004992Phase 3
• Study of Brain Activity During Speech Production and Speech PerceptionCompletedNCT00004991
• Once-A-Month Steroid Treatment for Patients With Focal Segmental GlomerulosclerosisCompletedNCT00004990Phase 2
• Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium BacteriaCompletedNCT00004988Phase 1
• The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)CompletedNCT00004984Phase 3
• Education and Group Support for Diabetic HispanicsCompletedNCT00004983Not applicable
• Combination Iron Chelation TherapyCompletedNCT00004982Phase 1
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating PolyneuropathyCompletedNCT00004939Phase 3
• Phase II Study of Fluconazole for Lymphocutaneous and Visceral SporotrichosisCompletedNCT00004938Phase 2
• Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon CancerCompletedNCT00004931Phase 3
• Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00004919Phase 1
• Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic SyndromeCompletedNCT00004918Phase 1/2
• O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004892Phase 1
• Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2CompletedNCT00004883Phase 2
• Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00004862Phase 1
• Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the UrotheliumTerminatedNCT00004856Phase 2
• Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsCompletedNCT00004855Not applicable
• The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart FailureCompletedNCT00004854Phase 1
• Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyCompletedNCT00004853Phase 1
• Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV QuasispeciesCompletedNCT00004851
• Epidemiology, Infectivity and Natural History of Hepatitis C Virus InfectionCompletedNCT00004850
• A Controlled Prospective Study of Transfusion-Associated HepatitisCompletedNCT00004848
• Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIVCompletedNCT00004846
• A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)CompletedNCT00004845Phase 2/3
• Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's DiseaseStatus unknownNCT00004844Not applicable
• A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary HyperparathyroidismCompletedNCT00004843Not applicable
• Pilot Study of Budesonide for Patients With Primary Sclerosing CholangitisCompletedNCT00004842Phase 1
• Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm InfantsCompletedNCT00004840Not applicable
• Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned ChildrenCompletedNCT00004838Not applicable
• Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic SeizuresCompletedNCT00004817Phase 3
• A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple SclerosisCompletedNCT00004816Phase 1
• Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's SyndromeCompletedNCT00004815Not applicable
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple SclerosisCompletedNCT00004814Phase 3
• Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord InjuryCompletedNCT00004812Phase 2
• Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and SporotrichosisCompletedNCT00004811Phase 1/2
• Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative ColitisCompletedNCT00004810Phase 2
• Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial HypercholesterolemiaCompletedNCT00004809Phase 1
• Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and SporotrichosisCompletedNCT00004808Phase 2
• Study of the Pathogenesis of Rett SyndromeCompletedNCT00004807Not applicable
• Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden DeathCompletedNCT00004805Not applicable
• Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis CCompletedNCT00004804Phase 3
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel DisordersCompletedNCT00004802Phase 3
• Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX DeficiencyCompletedNCT00004801Phase 1/2
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis VaccinesCompletedNCT00004800Phase 3
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis VaccinesCompletedNCT00004799Phase 3
• Pilot Study of Fructose for Sickle Cell CrisisCompletedNCT00004797Not applicable
• Phase II Study of Lactulose and Circadian Rhythms in Patients With CirrhosisCompletedNCT00004796Phase 2
• Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus ErythematosusCompletedNCT00004795Phase 2/3
• Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus RetinitisCompletedNCT00004794Phase 2
• Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal ChildrenCompletedNCT00004793
• Study of the Nutritional, Metabolic, and Body Composition Profile in Children and Adolescents With Epidermolysis BullosaCompletedNCT00004791
• Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute PorphyriaCompletedNCT00004789Phase 1/2
• Study of Nutritional Factors in PorphyriaCompletedNCT00004788
• Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure SyndromesCompletedNCT00004787Phase 2
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00004786Phase 3
• Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary DysplasiaCompletedNCT00004785Phase 3
• Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary CirrhosisCompletedNCT00004784Phase 3
• Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk GroupsCompletedNCT00004781

← National Institutes of Health overview and focus areas